Endothelin-1 in Subarachnoid Hemorrhage
Authors:
- 1 December 2000
- journal article
- research article
- Published by Wolters Kluwer Health in Stroke
- Vol. 31 (12) , 2971-2975
Abstract
Background and Purpose —The most potent vasoconstrictor known, endothelin-1, is currently considered to mediate cerebral vasospasm in subarachnoid hemorrhage (SAH), which can cause delayed cerebral ischemia. In our study, we performed clinical and in vitro experiments to investigate the origin and the mechanisms of the secretion of endothelin-1 in SAH. Methods —Endothelin-1 and markers of inflammatory host response (interleukin [IL]-1β, IL-6, and tumor necrosis factor-α) were comparatively quantified in the cerebrospinal fluid (CSF) of SAH patients and control subjects, and concentrations were related to clinical characteristics. Furthermore, mononuclear leukocytes isolated from the CSF of SAH patients and control subjects were analyzed regarding their mRNA expression of endothelin-1 and inflammatory cytokines. Finally, complementary in vitro experiments were performed to investigate whether coincubation of blood and CSF can trigger leukocytic mRNA expression and release of these factors. Results —Activated mononuclear leukocytes in the CSF of SAH patients synthesize and release endothelin-1 in parallel with known acute-phase reactants (IL-1β, IL-6, and tumor necrosis factor-α). Complementary in vitro experiments not only further confirmed this leukocytic origin of endothelin-1 but also showed that aging and subsequent hemolysis of blood is sufficient to induce such endothelin-1 production. Conclusions —The demonstration that endothelin-1 is produced by activated CSF mononuclear leukocytes suggests that subarachnoid inflammation may represent a therapeutic target to prevent vasospasm and delayed cerebral ischemia after SAH.Keywords
This publication has 32 references indexed in Scilit:
- Antisense preproendothelin-oligoDNA therapy for vasospasm in a canine model of subarachnoid hemorrhageJournal of Neurosurgery, 1999
- ?ndothelin: new discoveries and rapid progress in the clinicTrends in Pharmacological Sciences, 1998
- ANNOUNCEMENTNeurosurgery, 1997
- Intracranial AneurysmsNew England Journal of Medicine, 1997
- QUANTITATIVE PCR ANALYSIS OF CYTOKINE TRANSCRIPTION PATTERNS IN PERIPHERAL MONONUCLEAR CELLS AFTER ANTI-CD3 REJECTION THERAPY USING TWO NOVEL MULTISPECIFIC COMPETITOR FRAGMENTS1Transplantation, 1994
- The role of endothelin-1 in the origin of cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhageJournal of Neurosurgery, 1992
- The biosynthesis of endothelin-1 by human polymorphonuclear leukocytesBiochemical and Biophysical Research Communications, 1991
- Endothelin Immunoreactivity in Cerebrospinal Fluid of Patients with Subarachnoid HaemorrhageAnnals of Medicine, 1990
- Endothelin and the production of cerebral vasospasm in dogsBiochemical and Biophysical Research Communications, 1989
- Transcranial doppler ultrasound for the assessment of intracranial arterial flow velocity—Part 1. Examination technique and normal valuesSurgical Neurology, 1987